<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03115957</url>
  </required_header>
  <id_info>
    <org_study_id>201502022-22</org_study_id>
    <nct_id>NCT03115957</nct_id>
  </id_info>
  <brief_title>Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients</brief_title>
  <acronym>PNASIT</acronym>
  <official_title>Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients With Nutritional Risk and Initial Enteral Nutrition Intolerance: A Clinical Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jinling Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinqiao Hospital of Chongqing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qingdao University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Kunming Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jinling Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be randomized to early PN group or late PN group at day 3 after abdominal
      surgery. Patients will receive supplemental parenteral nutrition or not within 7 days after
      abdominal surgery. Both groups will receive SPN except 80% of target energy delivered by EN
      or oral or patients are discharged from hospital. The primary and secondary outcomes will be
      collected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients after abdominal surgery will attempt enteral nutrition support for 2 days, if she/he
      can not tolerate 30% of target energy, then she/he will be randomized to early PN group or
      late PN group at day 3. Patients in early PN group will receive supplemental parenteral
      nutrition at day 3 while patients in late PN group will not receive supplemental parenteral
      nutrition until day 8 after abdominal surgery. Both groups will receive SPN except 80% of
      target energy delivered by EN or oral or patients are discharged from hospital. The primary
      and secondary outcomes will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morbidity of infection</measure>
    <time_frame>From date of randomization until the date of infection from any cause, assessed up to 2 months.</time_frame>
    <description>Invasion of the host organism by microorganisms that can cause pathological conditions or diseases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital</measure>
    <time_frame>From date of operation until the date of patients discharged from hospital, assessed up to 12 months.</time_frame>
    <description>The length of patients stay in hospital after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>From date of randomization until the date of death, assessed up to 2 months after patients discharged from hospital.</time_frame>
    <description>All deaths reported in all enrolled patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale the frequency of gastrointestinal intolerance</measure>
    <time_frame>During the intervention, assessed up to 2 months.</time_frame>
    <description>Diarrhea, vomiting, abdominal distention or cramping and abdominal pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale actual calories intake</measure>
    <time_frame>During the intervention, assessed up to 2 months.</time_frame>
    <description>The total energy patients received during the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory examination</measure>
    <time_frame>At the date of patients enrollment and after intervention, assessed up to 2 months.</time_frame>
    <description>Albumin, pre-albumin, transferrin and retinol conjugated protein</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Digestive System Neoplasms</condition>
  <arm_group>
    <arm_group_label>Early PN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who can not tolerate 30% of target energy EN will receive supplemental parenteral nutrition at day 3 after abdominal surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed PN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who can not tolerate 30% of target energy EN will receive supplemental parenteral nutrition at day 8 after abdominal surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Parenteral Nutrition</intervention_name>
    <description>Patients who can not tolerate 30% of target energy EN will receive supplemental parenteral nutrition at day 3 or at day 8 after abdominal surgery.</description>
    <arm_group_label>Early PN</arm_group_label>
    <arm_group_label>Delayed PN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Informed consent of patients or their legal representatives to participate in this
             study.

          2. Patients undergoing selective operation without trauma

          3. Patients following medium or major abdominal surgery

          4. NRS 2002≥ 3

        Exclusion Criteria:

          1. Psychiatric disorders

          2. Pregnancy or breast-feeding women

          3. Malnutrition

               1. Weight loss &gt;10%-15% in 6 months

               2. BMI&lt;18.5

               3. SGA score with stage C

               4. Albumin &lt;30g/L

          4. Unstable vital signs or unstable hemodynamics (such as systolic blood pressure &lt; 90
             mmHg or mean arterial pressure &lt; 70 mmHg after rapid 500 ml crystal or 200 ml gel
             infusion, or the 50% increase of vascular active drug infusion rate in an hour, etc)

          5. Refuse to participate in the study

          6. Mortality rates expected to more than 50% in 6 months with malignant or
             irreversibility diseases

               1. Cancer in terminal stage

               2. HIV positive at end-stage or CD4 ＜ 50/mm3

               3. Cardiopulmonary resuscitation (CPR) before cardiac arrest and nervous system
                  function not fully recovery

               4. Four levels of physical activity of the patients defined by New York heart
                  association

               5. Rely on breathing machine because of chronic diseases

          7. Life expectancy less than 24 hours of dying patients

          8. Refractory shock to meet any of the following article

               1. The infusion rate of dopamine ＞ 15 ug/kg/min

               2. The infusion rate of dobutamine ＞ 15 ug/kg/min

               3. The infusion rate of epinephrine and norepinephrine ＞ 30 ug/min

               4. The infusion rate of phenylephrine ＞ 50 ug/min

               5. The infusion rate of milrinone ＞ 0.5 ug/kg/min

               6. The infusion rate of vasopressin ＞ 0.04 U/min

               7. Inter aortic ballon pump (IABP)

          9. Hepatic insufficiency (alanine/aspartate transaminase 200% above normal range)

         10. Renal insufficiency(creatinine 200% above normal range)

         11. Metabolic diseases（hyperthyroidism/ hypothyroidism, adrenal cortex disorders)

         12. EN can reach 30% of target energy in 48 hours after surgery

         13. Burn area exceeding 20% of the patient's body surface

         14. Autoimmune diseases or immune dysfunction or history of organ transplantation

         15. International standardization ratio (INR) more than 3.0 or platelet count ＜ 30000
             cells/mm3 or other hemorrhagic diathesis

         16. Intracranial hemorrhage one month before enrolment

         17. General contraindications to infusion therapy or history of severe allergy against
             ingredients of enteral and parenteral nutrition

         18. Has already participated in another clinical trial

         19. Has started to nutritional support therapy before enrolment

         20. Diabetes mellitus (anamnestic and/or under medical treatment)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinying Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jinling Hospital, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tingting Gao, MS</last_name>
    <phone>+86 15312311968</phone>
    <email>gaotting77@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>JinlingH</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinying Wang, MD</last_name>
      <phone>02580861429</phone>
      <email>wxinying@263.net</email>
    </contact>
    <contact_backup>
      <last_name>Feng Tian, MD</last_name>
      <phone>18205188526</phone>
      <email>tianfeng_nju@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Bauer P, Charpentier C, Bouchet C, Nace L, Raffy F, Gaconnet N. Parenteral with enteral nutrition in the critically ill. Intensive Care Med. 2000 Jul;26(7):893-900.</citation>
    <PMID>10990103</PMID>
  </reference>
  <reference>
    <citation>Desachy A, Clavel M, Vuagnat A, Normand S, Gissot V, François B. Initial efficacy and tolerability of early enteral nutrition with immediate or gradual introduction in intubated patients. Intensive Care Med. 2008 Jun;34(6):1054-9. doi: 10.1007/s00134-007-0983-6. Epub 2008 Jan 22.</citation>
    <PMID>18210092</PMID>
  </reference>
  <reference>
    <citation>Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH, Kahoul SH, Brits R. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr. 2011 Mar;93(3):569-77. doi: 10.3945/ajcn.110.005074. Epub 2011 Jan 26.</citation>
    <PMID>21270385</PMID>
  </reference>
  <reference>
    <citation>Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011 Aug 11;365(6):506-17. doi: 10.1056/NEJMoa1102662. Epub 2011 Jun 29.</citation>
    <PMID>21714640</PMID>
  </reference>
  <reference>
    <citation>Rice TW, Mogan S, Hays MA, Bernard GR, Jensen GL, Wheeler AP. Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure. Crit Care Med. 2011 May;39(5):967-74. doi: 10.1097/CCM.0b013e31820a905a.</citation>
    <PMID>21242788</PMID>
  </reference>
  <reference>
    <citation>Singer P, Anbar R, Cohen J, Shapiro H, Shalita-Chesner M, Lev S, Grozovski E, Theilla M, Frishman S, Madar Z. The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med. 2011 Apr;37(4):601-9. doi: 10.1007/s00134-011-2146-z. Epub 2011 Feb 22.</citation>
    <PMID>21340655</PMID>
  </reference>
  <reference>
    <citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, Morris A, Dong N, Rock P. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012 Feb 22;307(8):795-803. doi: 10.1001/jama.2012.137. Epub 2012 Feb 5.</citation>
    <PMID>22307571</PMID>
  </reference>
  <reference>
    <citation>Doig GS, Simpson F, Sweetman EA, Finfer SR, Cooper DJ, Heighes PT, Davies AR, O'Leary M, Solano T, Peake S; Early PN Investigators of the ANZICS Clinical Trials Group. Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA. 2013 May 22;309(20):2130-8. doi: 10.1001/jama.2013.5124.</citation>
    <PMID>23689848</PMID>
  </reference>
  <reference>
    <citation>Heidegger CP, Berger MM, Graf S, Zingg W, Darmon P, Costanza MC, Thibault R, Pichard C. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013 Feb 2;381(9864):385-93. doi: 10.1016/S0140-6736(12)61351-8. Epub 2012 Dec 3.</citation>
    <PMID>23218813</PMID>
  </reference>
  <reference>
    <citation>Braunschweig CA, Sheean PM, Peterson SJ, Gomez Perez S, Freels S, Lateef O, Gurka D, Fantuzzi G. Intensive nutrition in acute lung injury: a clinical trial (INTACT). JPEN J Parenter Enteral Nutr. 2015 Jan;39(1):13-20. doi: 10.1177/0148607114528541. Epub 2014 Apr 9.</citation>
    <PMID>24722769</PMID>
  </reference>
  <reference>
    <citation>Charles EJ, Petroze RT, Metzger R, Hranjec T, Rosenberger LH, Riccio LM, McLeod MD, Guidry CA, Stukenborg GJ, Swenson BR, Willcutts KF, O'Donnell KB, Sawyer RG. Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: a randomized controlled trial. Am J Clin Nutr. 2014 Nov;100(5):1337-43. doi: 10.3945/ajcn.114.088609. Epub 2014 Sep 3.</citation>
    <PMID>25332331</PMID>
  </reference>
  <reference>
    <citation>Peake SL, Davies AR, Deane AM, Lange K, Moran JL, O'Connor SN, Ridley EJ, Williams PJ, Chapman MJ; TARGET investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Use of a concentrated enteral nutrition solution to increase calorie delivery to critically ill patients: a randomized, double-blind, clinical trial. Am J Clin Nutr. 2014 Aug;100(2):616-25. doi: 10.3945/ajcn.114.086322. Epub 2014 Jul 2.</citation>
    <PMID>24990423</PMID>
  </reference>
  <reference>
    <citation>Petros S, Horbach M, Seidel F, Weidhase L. Hypocaloric vs Normocaloric Nutrition in Critically Ill Patients: A Prospective Randomized Pilot Trial. JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):242-9. doi: 10.1177/0148607114528980. Epub 2014 Apr 3.</citation>
    <PMID>24699555</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jinling Hospital, China</investigator_affiliation>
    <investigator_full_name>Wang Xinying</investigator_full_name>
    <investigator_title>Professor, Chief of Clinical Nutrition Service</investigator_title>
  </responsible_party>
  <keyword>Parenteral Nutrition</keyword>
  <keyword>Digestive System Neoplasms</keyword>
  <keyword>Randomized Controlled Trials</keyword>
  <keyword>Clinical Outcomes</keyword>
  <keyword>Postoperative Period</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Digestive System Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

